Recent Advances in Translational Neuro-Oncology
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuro-oncology".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 101
Special Issue Editors
2. School of Medicine, Boston University, Boston, MA 02118, USA
Interests: brain tumors; radiosurgery; neuro-oncology; gliomas; brain metastasis; nanomedicine; theranostics; DNA damage response; image-guided neurosurgery; disparities in neuro-oncology care; blood-brain barrier; patient-derived mouse models of brain tumors; genome-editing
2. Dana Farber Cancer Institute, Boston, MA 02215, USA
3. School of Medicine, Boston University, Boston, MA 02118, USA
4. Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada
Interests: brain tumors; radiosurgery; skull base surgery; neuro-oncology; management of brain tumors during pregnancy; gliomas; brain metastasis; pituitary tumors; intraventricular tumors; image-guided neurosurgery
Special Issue Information
Dear Colleagues,
Advances in understanding the molecular biology of brain tumors, combined with high-throughput screening platforms for therapeutic discovery, novel multimodal strategies that allow for maximally safe surgical tumor resection and downstream targeted adjuvant treatments, have the potential to significantly increase the survival of patients with primary and/or metastatic brain tumors.
In this Special Issue of Brain Sciences, we welcome submissions that present cutting-edge perspectives on recent developments in the fields of translational neuro-oncology, immune-oncology pertaining to the treatment of primary and metastatic brain tumors, and cancer neuroscience.
We explore the emerging use of artificial intelligence in the field of neuro-oncology, including its use in radiomics to assist in the diagnosis of brain tumors, its incorporation in the surgical management of brain tumors and as a tool to predict outcomes. We welcome submissions studying the uses of machine learning and data analytics to understand global real-world treatment patterns for primary and metastatic brain tumors.
Finally, we welcome original articles that probe the neuropsychiatric effects of treatments for all types of brain tumors, studies that explore the importance of neurorehabilitation before, during and after therapy, and the role of clinical nurse advocates in helping brain tumor patients and their families navigate complicated health systems and address disparities in the delivery of cancer care to this vulnerable patient population.
Dr. Fred C. Lam
Prof. Dr. Ekkehard Matthias Kasper
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- neuro-oncology
- neurosurgery
- radiosurgery
- immune-oncology
- translational research
- clinical trials
